Saturday 17 October 2026
Export LFCR’s income statement to Excel — free account
Lifecore Biomedical, Inc.
LFCR Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue fell 6.25%, EPS fell 216.7%, free cash flow fell 117.0% and total debt rose 15.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
6.38
0.06
−0.93%
Follow LFCR
| May '16 | May '17 | May '18 | May '19 | May '20 | May '21 | May '22 | May '23 | May '24 | May '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | 7 | 5 | 3 | 2 | 5 | 3 | 3 | 6 | 3 |
P/E ratio |
0.00 | 35.77 | 15.62 | 781.10 | 0.00 | 0.00 | 0.00 | 0.00 | 14.75 | 0.00 |
P/S ratio |
0.66 | 0.81 | 0.74 | 0.50 | 1.97 | 3.38 | 2.52 | 2.38 | 1.39 | 1.85 |
Altman Z-Score |
3.04 | 3.63 | 3.34 | 2.07 | 0.91 | 1.06 | 0.50 | 0.07 | 0.21 | 0.12 |
P/FCF ratio |
0.00 | 49.47 | 0.00 | 0.00 | 0.00 | 12.14 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.58 | 3.42 | 2.99 | 1.85 | 0.80 | 1.45 | (2.16) | (1.29) | (1.00) | (1.50) |
P/Operating CF |
21.85 | 57.36 | (745.19) | (196.87) | (24.89) | 58.08 | (510.82) | (108.47) | 20.42 | 44.74 |
Beneish M-Score |
(3.16) | (2.82) | (2.26) | (2.48) | (1.11) | (3.41) | (2.84) | (3.23) | (2.28) | (3.15) |
P/B ratio |
1.47 | 1.67 | 1.54 | 1.04 | 1.37 | 1.68 | 3.09 | 0.00 | 15.73 | 179.05 |
Price to Tangible BV |
2.22 | 2.54 | 2.20 | 1.90 | 2.56 | 2.38 | 3.88 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.76 | 0.92 | 0.87 | 0.77 | 3.16 | 5.29 | 3.84 | 3.80 | 2.49 | 2.97 |
EV/EBITDA |
0.00 | 15.07 | 15.63 | 15.80 | 40.66 | 25.57 | 6.97 | 308.09 | 39.86 | 0.00 |
EV/Operating CF |
15.81 | 12.17 | 17.55 | 20.61 | (15.83) | 15.28 | (15.88) | (18.80) | (47.08) | (74.55) |
EV/FCF |
(11.52) | 55.76 | (27.38) | (10.16) | (7.01) | 19.00 | (6.32) | (8.46) | (9.26) | (30.80) |
Quick Ratio |
1.00 | 1.01 | 0.64 | 0.52 | 0.47 | 0.42 | 0.22 | 1.22 | 0.91 | 1.22 |
Current Ratio |
1.53 | 1.58 | 1.10 | 0.97 | 0.96 | 1.46 | 0.66 | 2.39 | 2.08 | 2.84 |
Net Debt/EBITDA |
(4.56) | 1.89 | 2.69 | 7.14 | 32.11 | 17.45 | 1.74 | (20.15) | (158.92) | (15.59) |
Debt/Assets |
17.85% | 15.05% | 18.02% | 28.70% | 35.16% | 38.55% | 53.93% | 65.69% | 59.02% | 63.50% |
Debt/Equity |
0.29 | 0.24 | 0.29 | 0.55 | 0.82 | 0.96 | 1.69 | 4.75 | 2.78 | 3.20 |
Asset Turnover |
1.38 | 1.34 | 1.37 | 1.21 | 0.30 | 0.19 | 0.29 | 0.39 | 0.51 | 0.52 |
Operating CF/Net income |
(1.78) | 2.82 | 0.80 | 38.98 | 0.45 | (0.51) | 0.19 | 0.18 | 0.02 | 0.00 |
Capex/Depreciation |
(4.21) | (2.15) | (2.70) | (2.92) | (0.76) | (0.62) | (0.30) | (1.48) | (2.31) | (0.80) |
Interest Coverage |
(10.38) | 8.03 | 6.97 | 1.05 | (5.57) | (0.99) | (0.76) | (1.24) | (0.49) | (0.79) |
| (5.38%) | 4.81% | 10.33% | 0.16% | (15.24%) | (14.89%) | (80.32%) | (238.21%) | 339.11% | (701.27%) | |
| (3.38%) | 3.02% | 6.51% | 0.09% | (7.20%) | (6.19%) | (30.02%) | (37.70%) | 4.73% | (17.98%) | |
ROIC |
(4.89%) | 3.32% | 2.63% | 0.82% | (3.84%) | (1.39%) | (3.14%) | (7.46%) | (2.83%) | (5.64%) |
Return on Tangible Assets |
(7.72%) | 6.50% | 14.75% | 0.21% | (20.64%) | (19.37%) | (198.64%) | (52.69%) | 6.28% | (24.04%) |
Average Days of Receivables |
35.52 | 35.66 | 37.51 | 45.54 | 173.77 | 149.91 | 125.68 | 102.58 | 77.07 | 81.26 |
Research and Development Expense of Revenue |
1.52% | 2.02% | 2.44% | 2.06% | 4.74% | 6.63% | 7.05% | 8.46% | 6.69% | 6.41% |
Selling, General and Administrative Expense of Revenue |
9.68% | 11.17% | 9.91% | 11.13% | 25.41% | 27.48% | 31.15% | 37.74% | 31.55% | 34.18% |
Intangible Assets out of Total Assets |
0.21 | 0.22 | 0.19 | 0.24 | 0.20 | 0.12 | 0.07 | 0.07 | 0.07 | 0.08 |
Share Based Compensation of Revenue |
0.73% | 0.84% | 0.84% | 0.64% | 1.51% | 3.33% | 2.34% | 3.50% | 4.83% | 7.88% |
Graham Net Nets |
(0.14) | (0.13) | (0.14) | (0.41) | (0.48) | (0.45) | (0.23) | (0.51) | (0.67) | (0.44) |
Graham Number |
0.00 | 8.58 | 13.65 | 1.65 | 0.00 | 0.00 | 0.00 | 3.19 | 1.82 | 0.00 |
Earnings Yield |
(3.72%) | 2.80% | 6.40% | 0.13% | (12.09%) | (9.60%) | (34.85%) | (39.04%) | 6.78% | (16.30%) |
Free Cash Flow Yield |
(10.10%) | 2.02% | (4.31%) | (15.01%) | (22.84%) | 8.24% | (24.16%) | (18.93%) | (19.38%) | (5.21%) |
Revenue per Share |
17.63 | 17.22 | 19.04 | 19.66 | 5.49 | 3.44 | 3.78 | 3.45 | 4.21 | 3.70 |
Operating CF per Share |
0.77 | 1.09 | 0.72 | 0.56 | (0.58) | 0.56 | (0.77) | (0.58) | 0.01 | (0.01) |
Capex per Share |
(1.46) | (0.84) | (1.22) | (1.57) | (0.83) | (0.42) | (0.98) | (0.72) | (0.60) | (0.18) |
Free Cash Flow per Share |
(0.70) | 0.25 | (0.50) | (1.00) | (1.42) | 0.14 | (1.74) | (1.30) | (0.60) | (0.19) |
Cash per Share |
0.37 | 0.22 | 0.11 | 0.04 | 0.01 | 0.04 | 0.03 | 0.64 | 0.28 | 0.24 |
Shareholders Equity per Share |
7.85 | 8.36 | 9.17 | 9.53 | 7.92 | 6.92 | 2.98 | 1.17 | 1.77 | 1.36 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.85 | 8.36 | 9.17 | 9.53 | 7.92 | 6.92 | 2.98 | 1.17 | 1.77 | 1.36 |
Free Cash Flow |
(18.81) | 6.92 | (13.71) | (28.45) | (41.29) | 4.16 | (51.39) | (38.92) | (18.14) | (6.62) |
Working Capital |
29.96 | 29.83 | 8.69 | (4.05) | (7.28) | 46.43 | (59.91) | 54.59 | 42.16 | 55.50 |
Capital Expenditures |
(39.57) | (22.92) | (33.49) | (44.47) | (24.25) | (12.31) | (28.80) | (21.48) | (18.39) | (6.41) |
Net Current Asset Value |
(44.00) | (49.18) | (55.08) | (115.91) | (153.16) | (151.82) | (70.21) | (124.58) | (119.02) | (106.23) |
EV/EBIT |
0.00 | 29.34 | 33.73 | 78.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.08 | 0.05 | 0.06 | 0.08 | 0.15 | 0.12 | 0.26 | 0.21 | 0.14 | 0.05 |
Price to Operating Income |
0.00 | 26.03 | 28.57 | 51.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.08 | 0.08 | 0.08 | 0.08 | 0.17 | 0.17 | 0.81 | 0.11 | 0.05 | 0.06 |
Cash ROIC |
(6.64%) | 2.40% | (4.18%) | (6.77%) | (9.79%) | 1.05% | (21.69%) | (17.63%) | (8.55%) | (3.19%) |
Accounts Receivable Turnover |
10.27 | 10.18 | 10.51 | 9.03 | 2.20 | 1.72 | 2.79 | 3.07 | 4.57 | 4.62 |
Accounts Payable Turnover |
12.44 | 14.09 | 15.07 | 10.75 | 2.29 | 1.82 | 4.94 | 4.30 | 4.50 | 7.21 |
Inventory Turnover |
16.22 | 15.89 | 16.09 | 11.09 | 2.00 | 0.96 | 1.46 | 1.96 | 2.14 | 2.45 |
Average Days of Payables |
27.50 | 22.92 | 28.38 | 41.34 | 156.21 | 96.05 | 65.47 | 107.13 | 68.99 | 33.88 |
Days of Inventory on Hand |
22.72 | 22.07 | 26.05 | 41.46 | 200.56 | 371.71 | 181.98 | 198.01 | 168.87 | 133.07 |
Average Receivables |
46.44 | 46.15 | 49.89 | 61.72 | 72.89 | 58.82 | 39.87 | 33.67 | 28.05 | 27.89 |
Average Payables |
32.96 | 27.72 | 29.60 | 44.32 | 52.81 | 33.97 | 14.63 | 17.52 | 19.22 | 12.28 |
Average Inventory |
25.28 | 24.58 | 27.72 | 42.98 | 60.22 | 64.69 | 49.54 | 38.42 | 40.41 | 36.14 |
Average Assets |
344.56 | 350.63 | 381.66 | 461.90 | 530.20 | 522.12 | 388.81 | 264.12 | 253.75 | 246.65 |
Average Common Equity |
216.23 | 220.25 | 240.36 | 261.35 | 250.59 | 216.91 | 145.30 | 41.80 | 3.54 | 6.33 |
Columns are period end dates